BCWORLD PHARM. Co. Ltd (200780) - Total Liabilities

Latest as of September 2025: ₩101.30 Billion KRW ≈ $68.65 Million USD

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has total liabilities worth ₩101.30 Billion KRW (≈ $68.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BCWORLD PHARM. Co. Ltd operating cash flow efficiency to assess how effectively this company generates cash.

BCWORLD PHARM. Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check BCWORLD PHARM. Co. Ltd (200780) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

BCWORLD PHARM. Co. Ltd Competitors by Total Liabilities

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
D P Wires Limited NSE:DPWIRES	India	Rs-2.48 Billion
Heeros Oyj HE:HEEROS	Finland	€3.43 Million
Green Critical Minerals Ltd AU:GCM	Australia	AU$592.06K
MPC Energy Solutions NV OL:MPCES	Norway	Nkr79.42 Million
HLscience Co. Ltd KQ:239610	Korea	₩2.15 Billion
Focus Graphite Inc V:FMS	Canada	CA$4.13 Million
Carbochim SA RO:CBC	Romania	RON38.42 Million
Central Motek Co Ltd KO:308170	Korea	₩247.28 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down BCWORLD PHARM. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 200780 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BCWORLD PHARM. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual total liabilities of BCWORLD PHARM. Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩99.65 Billion ≈ $67.53 Million	-2.75%
2023-12-31	₩102.47 Billion ≈ $69.44 Million	-1.00%
2022-12-31	₩103.50 Billion ≈ $70.14 Million	+5.72%
2021-12-31	₩97.90 Billion ≈ $66.35 Million	+7.27%
2020-12-31	₩91.27 Billion ≈ $61.85 Million	+20.83%
2019-12-31	₩75.53 Billion ≈ $51.19 Million	+5.42%
2018-12-31	₩71.65 Billion ≈ $48.56 Million	+93.06%
2017-12-31	₩37.11 Billion ≈ $25.15 Million	+64.62%
2016-12-31	₩22.54 Billion ≈ $15.28 Million	+88.58%
2015-12-31	₩11.96 Billion ≈ $8.10 Million	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$30.55 Million

₩45.09 Billion KRW

Market Cap Rank

#23644 Global

#1696 in Korea

Share Price

₩4410.00

Change (1 day)

-0.79%

52-Week Range

₩4210.00 - ₩5870.00

All Time High

₩30700.49